SCHEDULE: Bank of Nova Scotia Discloses 3.37% Innoviva Stake

Bank of Nova Scotia reported a beneficial ownership of 3.37% in Innoviva, Inc., holding 2,179,005 shares of common stock as of September 30, 2025.

Summary

• Bank of Nova Scotia beneficially owns 2,179,005 shares of Innoviva, Inc. common stock.
• This ownership represents 3.37% of Innoviva, Inc.'s total outstanding common stock.
• Bank of Nova Scotia holds sole voting power and sole dispositive power over all 2,179,005 shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to previously reported beneficial ownership.
• Bank of Nova Scotia is classified as a bank and a parent holding company for the purpose of this filing.

Sentiment

Score: 5

Explanation: This filing is a routine disclosure of passive beneficial ownership and does not contain information that would significantly alter the company's operational or financial sentiment.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding Innoviva, Inc.'s future performance or operations.

Industry Context

This is a routine regulatory disclosure by a major financial institution, Bank of Nova Scotia, indicating a passive investment stake in Innoviva, Inc. Such filings provide transparency into institutional ownership, which is a standard practice in the financial industry for large banks managing investment portfolios.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's passive stake in Innoviva, Inc.
• Regulatory Authorities: Ensures compliance with beneficial ownership reporting requirements by Bank of Nova Scotia.

Key Dates

Recommendation

This Schedule 13G filing is a regulatory disclosure of a passive ownership stake by Bank of Nova Scotia in Innoviva, Inc. It does not provide any new operational, financial, or strategic information about Innoviva that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a compelling reason to buy or sell.

Keywords

Innoviva, Bank of Nova Scotia, common stock, beneficial ownership, Schedule 13G, institutional investor, equity stake